This announcement is a separate document:
以岭药业：2022年半年度报告摘要
Eling Pharmaceutical: 2022 Semi-Annual Report Summary
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.